Brain Activation in Uremic Anorexia

Journal of Renal Nutrition

Volumn 17, Issue 1, 2007, Pages 57-61

  Aguilera, Abelardo ^a   Sánchez Tomero, José Antonio ^a   Selgas, Rafael ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYTOKINE; LEPTIN; NITRIC OXIDE; SEROTONIN;

ANOREXIA; ARTICLE; BRAIN; FOOD INTAKE; HUMAN; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; UREMIA;

AMINO ACIDS; ANOREXIA; APPETITE REGULATION; BRAIN; CYTOKINES; HUMANS; LEPTIN; NITRIC OXIDE; SEROTONIN; UREMIA;

EID: 33845871456     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2006.10.020     Document Type: Article

References (33)

1. Bergström J. Appetite in CAPD patients. Perit Dial 16 suppl 1 (1996) S181-S184
2. Owen W., Lew N., Luí Y., et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329 (1993) 1001-1006
3. Aguilera A., Selgas R., Diéz J.J., et al. Anorexia in end-stage renal disease: Pathophysiology and treatment. Expert Opin Pharmacother 2 (2001) 1825-1838
4. Stricker E.M. Biological bases of hunger and satiety: Therapeutic implications. Nutr Rev 42 (1984) 333-340
5. Butler A.A., Marks D.L., Fan W., et al. Melanocortin-4 receptor is required for acute homeostatic responses to increase dietary fat. Nat Neurosci 4 (2001) 605-611
6. Batterham R.L., Cowley M.A., Small C.J., et al. Gut hormone PYY3-36 physiologically inhibits food intake. Nature 418 (2002) 650-654
7. Anderson G.H., Li E.T.S., Anthony S.P., et al. Dissociation between plasma and brain amino acid profiles and short-term food intake in the rat. Am J Physiol 35 (1994) R1675-R1686
8. Dube M.G., Xu B., Crowley W.R., et al. Evidence that neuropetide Y is a physiological signal of normal food intake. Brain Res 646 (1994) 341-344
9. Plata-Salamán C. Cytokines and feeding suppression: An integrative view from neurologic to molecular levels. Nutrition 11 suppl 5 (1995) 674-677
10. MacDonald C., Rush D., Bernstein K., et al. Production of tumoral necrosis factor in hemodialysis. Nephron 65 (1993) 273-277
11. Kapás L., Hong L., Cady A.B., et al. Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor alpha and TNF-α fragments. Am J Physiol 263 (1993) R708-R715
12. Treget E.E., Yu Y.M., Zhong S., et al. Role of interleukin 1 and tumor necrosis factor in energy metabolism in rabbits. Am J Physiol 255 (1988) E760-E768
13. Bellinger L.L., Williams F.E., Rogers Q.R., et al. Liver denervation attenuate the hypophagia produced by an imbalanced acid diet. Physiol Behav 59 (1996) 925-929
14. Cangiano C., Laviano A., Muscaritoli M., et al. Cancer anorexia: New pathogenic and therapeutic insights. Nutrition 12 (1996) S48-S50
15. Squadrito F., Calapai D., Altavilla D., et al. Central serotonergic system involvement in the anorexia induced by NG-nitro-L-arginine, an inhibitor of nitric oxide synthase. Eur J Pharmacol 255 (1994) 51-55
16. Kuhn D.M., and Arthur R. Molecular mechanism of the inactivation of tryptophan hydroxylase by nitric oxide: Attack on critical sulfhydryls that spare the enzyme iron center. J Neurosci 17 (1997) 7245-7251
17. Ritz E., Villance P., and Nowicki M. The effect of malnutrition on cardiovascular mortality in dialysis patients: Is L-arginine the Answer?. Nephol Dial Transplant 9 (1994) 129-130
18. Aguilera A., Codoceo R., Selgas R., et al. Anorexigen (TNF-α, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: Their relationship with nutritional parameters. Nephrol Dial Transpl 13 (1998) 1476-1483
19. Brenner D., Buck M., Feitelberg S., et al. Tumor necrosis factor alpha inhibits albumin gene expression in a murine model of cachexia. J Clin Invest 85 (1990) 248-255
20. Vallance P., Leone A., Calver A., et al. Accumulation of an endogenous inhibitor nitric oxide synthesis in chronic renal failure. Lancet 339 (1992) 572-575
21. Ando T., and Dunn A.J. Mouse tumor necrosis factor alpha increases brain tryptophan concentrations and norepinephrine metabolism while activating the HPA axis in nice. Neuroimmunomodulation 6 (1999) 319-329
22. Stenvinkel P. Leptin-A new hormone of definite interest for the nephrologist. Nephrol Dial Transplant 13 (1998) 1099-1101
23. Converse R.L., Jacobsen T.N., Toto R.D., et al. Symphathetic overactivity in patients with chronic renal failure. N Engl J Med 327 (1992) 1912-1918
24. Isse T., Ueta Y., Serino R., et al. Effects of leptin on fasting-induced inhibition of neural nitric oxide synthase mRNA in paraventricular and supraoptic nuclei of rats. Brain Res 846 (1999) 229-235
25. Laviano A., Cangiano C., Preziosa I., et al. Plasma tryptophan and anorexia in liver cirrhosis. Int J Eating Disord 21 (1996) 181-186
26. Siassi F., Wang M., Kopple J.D., et al. Plasma tryptophan levels and brain serotonin metabolism in chronically uremic rats. J Nutr 107 (1977) 840-845
27. Leibowitz S.F., and Alexander J.T. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry 44 (1998) 851-864
28. Niebauer J., Volk H.D., Kemp M., et al. Endotoxin and immune activation in chronic heart failure: A prospective cohort study. Lancet 353 (1999) 1838-1842
29. Cheung W., Yu P.X., Little B.M., et al. Role of leptin and melanocortin signalling in uremia-associated cachexia. J Clin Invest 115 (2005) 1659-1665
30. Aguilera A., Codoceo R., Bajo M.A., et al. Eating behavior disorders in uremia: A question of balance in appetite regulation. Semin Dial 17 (2004) 44-52
31. Chaki S., Hirota S., Funakoshi T., et al. Anxiolytic-like and antidepressant-like activities of MCLO129 (1-((S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl) ethyl)-4-(2-methoxynaphthalen-1-yl) butyl) piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor. J Pharmacol Exp Therap 304 (2003) 818-826
32. Li J.Y., Finniss S., Yang Y.K., et al. Agouti-related protein-like immunoreactivity: Characterization of release from hypothalamic tissue and presence in serum. Endocrinology 141 (2000) 1942-1950
33. Nonogaki K., Ohashi-Nozue K., and Oka Y. A negative feedback system between brain serotonin systems and plasma active ghrelin levels has been described in mice. Biochem Biophys Res Commun 341 (2006) 703-707